Journal of Neuroimmunology
Volume 178, Issue 1 , Pages 40-48 , September 2006

Retinal ganglion cell damage induced by spontaneous autoimmune optic neuritis in MOG-specific TCR transgenic mice

  • Yangtai Guan

      Affiliations

    • Department of Neurology, Thomas Jefferson University, 900 Walnut Street, Philadelphia, PA 19107, USA
    • Department of Neurology, Shanghai Changhai Hospital, Second Military Medical University, 174 Changhai Road, Shanghai 200433, P.R. China
    • Corresponding Author InformationCorresponding author. Department of Neurology, Thomas Jefferson University, 900 Walnut Street, Philadelphia, PA 19107, USA. Tel.: +1 215 955 2583; fax: +1 215 503 5848.
  • ,
  • Kenneth S. Shindler

      Affiliations

    • Department of Ophthalmology, University of Pennsylvania, Scheie Eye Institute, 51 N. 39th Street, Philadelphia, PA 19104, USA
    • Tel.: +1 215 662 8042; fax: +1 215 243 4694.
  • ,
  • Philomela Tabuena

      Affiliations

    • Department of Neurology, Thomas Jefferson University, 900 Walnut Street, Philadelphia, PA 19107, USA
  • ,
  • A.M. Rostami

      Affiliations

    • Department of Neurology, Thomas Jefferson University, 900 Walnut Street, Philadelphia, PA 19107, USA

Received 3 February 2006 ,Revised 16 May 2006 ,Accepted 17 May 2006.

References 

  1. Arnold AC. Evolving management of optic neuritis and multiple sclerosis. Am. J. Ophthalmol. 2005;139:1101–1108
  2. Beck RW, Cleary PA, Anderson MM, Keltner JL, Shults WT, Kaufman DI, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N. Engl. J. Med. 1992;326:581–588
  3. Bettelli E, Pagany M, Weiner HL, Linington C, Sobel RA, Kuchroo VK. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 2003;197:1073–1081
  4. Bjartmar C, Kidd G, Mork S, Rudick R, Trapp BD. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann. Neurol. 2000;48:893–901
  5. Constantinescu CS, Hilliard B, Fujioka T, Bhopale MK, Calida D, Rostami AM. Pathogenesis of neuroimmunologic diseases. Immunol. Res. 1998;17:217–227
  6. De Stefano N, Guidi L, Stromillo ML, Bartolozzi ML, Federico A. Imaging neuronal and axonal degeneration in multiple sclerosis. Neurol. Sci. 2003;24(Suppl. 5):S283–S286
  7. Diem R, Taheri N, Dietz GP, Kuhnert A, Maier K, Sattler MB, et al. HIV-Tat-mediated Bcl-XL delivery protects retinal ganglion cells during experimental autoimmune optic neuritis. Neurobiol. Dis. 2005;20:218–226
  8. Ghezzi A, Martinelli V, Torri V, Zaffroni M, Rodeheger M, Comi G, et al. Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J. Neurol. 1999;246:770–775
  9. Hobom M, Storch MK, Weissert R, Maier K, Radhakrishnan A, Kramer B, et al. Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis. Brain Pathol. 2004;14:148–157
  10. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, et al. Multiple sclerosis and chronic autoimmune encephalomyelitis. Am. J. Pathol. 2000;157:267–276
  11. Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell. 1994;78:399–408
  12. Maier K, Rau CR, Storch MK, Sattler MB, Demmer I, Weissert R, et al. Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats. Brain Pathol. 2004;14:378–387
  13. Mendel I, Kerlero de Rosbo N, Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 1995;25:1951–1959
  14. Meyer R, Weissert R, Diem R, Storch MK, de Graaf KL, Kramer B, et al. Acute neuronal apoptosis in a rat model of multiple sclerosis. J. Neurosci. 2001;21:6214–6220
  15. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. New Engl. J. Med. 2000;343:938–952
  16. O'Neill JK, Baker D, Morris MM, Gschmeissner SE, Jenkins HG, Butt AM, et al. Optic neuritis in chronic relapsing experimental allergic encephalomyelitis in Biozzi ABH mice: demyelination and fast axonal transport changes in disease. J. Neuroimmunol. 1998;82:210–218
  17. Optic Neuritis Study Group . The clinical profile of optic neuritis. Arch. Ophthalmol. 1991;109:1673–1678
  18. O'Riordan JI, Thompson AJ, Kingsley DP, MacManus DG, Kendall BE, Rudge P, et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain. 1998;121:495–503
  19. Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest. Ophthalmol. Visual Sci. 1999;40:2520–2527
  20. Raine CS, Traugott U, Nussenblatt RB, Stone SH. Optic neuritis and chronic relapsing experimental allergic encephalomyelitis: relationship to clinical course and comparison with multiple sclerosis. Lab. Invest. 1980;42:327–335
  21. Sakuma H, Kohyama K, Park IK, Miyakoshi A, Tanuma N, Matsumoto Y. Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats. Brain. 2004;127:2201–2213
  22. Shao H, Huang Z, Sun SL, Kaplan HJ, Sun D. Myelin/oligodendrocyte glycoprotein-specific T- cells induce severe optic neuritis in the C57B1/6 mouse. Invest. Ophthalmol. Visual Sci. 2004;45:4060–4065
  23. Shindler, K.S., Guan, Y.T., Venture, E., Bennett, F., Rostami, A.M., in press. Retinal Ganglion Cell Loss Induced by Acute Optic Neuritis in a Relapsing Model of Multiple Sclerosis. Multiple Sclerosis.
  24. Söderström M, Jin YP, Hillert J, Link H. Optic neuritis. Prognosis for multiple sclerosis from MRI, CSF and HLA findings. Neurology. 1998;50:708–714
  25. Steel DHW, Waldock A. Measurement of the retinal nerve fibre layer with scanning laser polarimetry in patients with previous demyelinating optic neuritis. J. Neurol. Neurosurg. Psychiatry. 1998;64:505–509
  26. Storch MK, Stefferl A, Brehm U, Weissert R, Wallstrom E, Kerchensteiner M, et al. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 1998;8:681–694
  27. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. New Engl. J. Med. 1998;338:278–285
  28. Trip SA, Schlottmann PG, Jones SJ, Altmann DR, Garway-Heath DF, Thompson AJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann. Neurol. 2005;58:383–391
  29. Waldner H, Whitters MJ, Sobel RA, Collins M, Kuchroo VK. Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor. Proc. Natl. Acad. Sci. U. S. A. 2000;97:3412–3417
  30. Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, et al. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J. Neuropathol. Exp. Neurol. 2002;61:23–32
  31. Zhang GX, Yu S, Gran B, Rostami AM. Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response. J. Immunol. 2005;175:7202–7208

PII: S0165-5728(06)00197-4

doi: 10.1016/j.jneuroim.2006.05.019

Journal of Neuroimmunology
Volume 178, Issue 1 , Pages 40-48 , September 2006